Sun Pharmaceutical Industries
Signals mentioning Sun Pharmaceutical Industries
- India pharma market grows 13% in August as GLP-1 therapies accelerate
- Sun Pharma, USV and Cipla deepen wellness bets as GLP-1 demand reshapes nutrition
- India pharma market grows 12.1% in July as Sun Pharma and Zydus outpace sector
- Delhi HC requires Sun Pharma to secure approval before semaglutide tablet launch
- Delhi HC pauses Sun Pharma’s oral semaglutide launch in Novo Nordisk patent case
- Sun Pharma’s India growth and launches offset US generics weakness in Q1FY27
- Sun Pharma voluntarily recalls 11 eye-drop products from India market
- HDFC Securities includes ITC in broad post-Q1FY27 coverage review
- Sun Pharma recalls select eye drops, halts distributor sales as precaution
- Sun Pharma misses Q1 estimates as US generics sales fall 9.7%
- Sun Pharma Q1 profit rises 27% as India formulations sales grow 16%
- Sun Pharma wins Brazil approval for semaglutide, plans Hypera-led launch
- Nykaa founder Falguni Nayar named Trailblazer of the Year at NDTV Profit awards
- Sun Pharma’s $11.8B Organon deal lifts pharma M&A value despite volume slump
- Indian pharma stocks slide as Trump outlines tariffs of up to 200% on generic drugs
- Retail leads India dealmaking with 95 deals as Q2 M&A/PE values double to $36.3 billion
- DCGI orders nationwide crackdown on illegal sildenafil, tadalafil sales across pharmacies and e-platforms